Weekly Wrap: Funds for Dividend-Seekers and Steps for Rebalancing in Retirement Plans
We recap the week on Morningstar.com and note the most popular stocks, funds, and exchange-traded funds.
|Editor's note: Read the latest on how the coronavirus is rattling the markets and what investors can do to navigate it.|
4 Funds and ETFs with Tantalizing Dividend Yields
It has been a tough year for dividend-seekers, but these funds balance high payouts with volatility control.
Utility Dividend Leaders and Laggards
In a post-pandemic world, most utilities' dividends offer investors an attractive income alternative.
Do 401(k) Plans Still Make Sense?
Yes, but perhaps the system requires additional support.
How to Create Cash Flows in Retirement
Six key steps for incorporating rebalancing into your retirement plan.
The Model Portfolio Landscape in 5 Charts
What to know about the rapidly growing list of third-party model portfolios advisors have to choose from.
What Prior Market Crashes Can Teach Us About Navigating the Current One
The regularity of market crashes is a reminder that patience is key to investing in equity markets.
Portfolio Planning and Personal Finance With Christine Benz
3 Excellent Dividend Growth Funds and ETFs
Dividend-growth strategies tend to hold up well on the downside--an important attraction in 2020's volatile market.
RMDs Are On Hold for 2020. Now What?
How to decide whether you still want to take them.
Is the 60/40 Portfolio Dead?
Reports of the strategy's demise are greatly exaggerated.
Keeping Up With Momentum Investing
We explain what it is and share one of our favorites.
Putting the Olympics on Hold Isn't Keeping ETF Investors From Going for Gold
Gold ETFs stood atop the podium in July.
3 Equity Funds to Watch: The Latest Additions to Morningstar's Prospects List
Get to know some equity funds and fund managers that have impressed our analysts this year.
Value Investing Revisited
The methods may need fine-tuning, but fundamentals still drive returns.
4 Good Funds With Big Outflows
Investors are throwing these funds overboard. Should they?
Innovation Supports Growth at Big Pharma/Big Biotech Companies
Moats and returns on invested capital look stable for companies with a solid list of pipeline drugs.
4 Stocks With Sluggish Dividend Growth Potential
These utilities will struggle to increase their dividends.
Investing in Travel in Uncertain Times
Demand has been hindered but not permanently impaired by COVID-19.
Stock Analyst Updates
Disney Posts Mixed Q3 Due to Coronavirus; Mulan to PVOD
Despite a COVID-19-related revenue drop, the long-term outlook is positive as Disney continues to expand its direct relationships with consumers around the world. We maintain our wide moat and our $127 fair value estimate.
Favorable Tax Developments Boost CVS Outlook
We continue to view shares as undervalued for the narrow-moat company.
Uber's Delivery Demand Stays Strong, Mobility Suffers
We are maintaining our fair value estimate for the narrow-moat company and view shares as attractive.
The Long View
Burton Malkiel: 'I Am Not a Big Fan of ESG Investing'
The influential author and researcher shares his views on retirement income, asset allocation, equity valuations, whether indexing has gotten too big, and more.
Insights From Michelle Singletary: Diversity in Financial Services
"When you have a society where the wealth gap is so huge, we have a situation like we have now where when those folks fall, it brings all of us down, and we don't want that. There is enough for everybody," writes The Washington Post columnist.
Sequence of Returns: What It Means and How to Deal
The order of when things happen can be your friend or foe.
Baby Steps for Reducing Risk
Investors can take smaller steps to reduce a portfolio's risk profile without making a sweeping overhaul.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.